gatifloxacin has been researched along with Stroke in 2 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cannon, CP | 2 |
Braunwald, E | 2 |
McCabe, CH | 1 |
Grayston, JT | 1 |
Muhlestein, B | 1 |
Giugliano, RP | 1 |
Cairns, R | 2 |
Skene, AM | 1 |
Mega, JL | 1 |
Morrow, DA | 1 |
Murphy, S | 1 |
Ridker, PM | 1 |
2 trials available for gatifloxacin and Stroke
Article | Year |
---|---|
Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome.
Topics: Aged; Angina, Unstable; Anti-Bacterial Agents; Cardiovascular Diseases; Chlamydophila Infections; Ch | 2005 |
Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy.
Topics: Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cholesterol; Epidemiologic Methods; Female | 2006 |